从字节到床旁:重症监护病房人工智能应用的系统综述
该系统综述检索Embase、Medline、Web of Science Core Collection和Cochrane Central Register of Controlled Trials数据库,纳入494项使用人工智能分析ICU数据的研究。最常见设计为回顾性研究(476项,96.4%),前瞻性观察研究8项(1.6%),临床试验10项(2%)。378项(80.9%)回顾性研究被PROBAST评为高偏倚风险。未发现任何研究报告人工智能模型整合入常规临床实践后的结局评价。结论是绝大多数ICU人工智能模型仍处于测试和原型环境,仅少数在临床实践中评估。
要点
- 共纳入494项研究,回顾性设计占476项(96.4%),前瞻性观察研究仅8项(1.6%),临床试验仅10项(2%)。
- 378项(80.9%)回顾性研究经PROBAST评估为高偏倚风险。
- 未发现任何研究报告人工智能模型整合入常规临床实践后的结局评价。
- 绝大多数ICU人工智能模型仍停留在测试和原型环境,仅少数在临床实践中评估。
适用人群与场景
- 使用人工智能分析ICU数据的研究,纳入标准为使用AI分析ICU数据的研究;具体纳入/排除人群原文未提及。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 系统综述纳入494项研究;回顾性研究476项(96.4%),前瞻性观察研究8项(1.6%),临床试验10项(2%);378项(80.9%)回顾性研究PROBAST评为高偏倚风险;未发现报告AI模型整合入常规临床实践后结局评价的研究。
证据类型、等级与局限
- 研究类型为系统综述;采用PROBAST评估个体研究偏倚风险;局限:绝大多数为回顾性研究(96.4%),80.9%回顾性研究高偏倚风险,缺乏临床实践整合后的结局评价。
对床旁实践的改变
- 原文未提及
指南或共识出处
- Intensive Care Med 发表的系统综述《Moving from bytes to bedside: a systematic review on the use of artificial intelligence in the intensive care unit》
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Due to the increasing demand for intensive care unit (ICU) treatment, and to improve quality and efficiency of care, there is a need for adequate and efficient clinical decision-making. The advancement of artificial intelligence (AI) technologies has resulted in the development of prediction models, which might aid clinical decision-making. This systematic review seeks to give a contemporary overview of the current maturity of AI in the ICU, the research methods behind these studies, and the risk of bias in these studies.
METHODS: A systematic search was conducted in Embase, Medline, Web of Science Core Collection and Cochrane Central Register of Controlled Trials databases to identify eligible studies. Studies using AI to analyze ICU data were considered eligible. Specifically, the study design, study aim, dataset size, level of validation, level of readiness, and the outcomes of clinical trials were extracted. Risk of bias in individual studies was evaluated by the Prediction model Risk Of Bias ASsessment Tool (PROBAST).
RESULTS: Out of 6455 studies identified through literature search, 494 were included. The most common study design was retrospective [476 studies (96.4% of all studies)] followed by prospective observational [8 (1.6%)] and clinical [10 (2%)] trials. 378 (80.9%) retrospective studies were classified as high risk of bias. No studies were identified that reported on the outcome evaluation of an AI model integrated in routine clinical practice.
CONCLUSION: The vast majority of developed ICU-AI models remain within the testing and prototyping environment; only a handful were actually evaluated in clinical practice. A uniform and structured approach can support the development, safe delivery, and implementation of AI to determine clinical benefit in the ICU.
参考来源
- van de Sande D, van Genderen ME, Huiskens J, et al. Moving from bytes to bedside: a systematic review on the use of artificial intelligence in the intensive care unit. Intensive Care Med. 2021. PMID: 34089064. doi:10.1007/s00134-021-06446-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。